Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.

Dr. Stefan  Lutz Ph.D.

Senior Vice President of Research

Mr. Robert  Sato M.B.A., Ph.D.

Senior Vice President of Pharmaceutical Development, Quality & Regulatory

Dr. Stephen George Dilly MBBS, Ph.D.

President, Chief Executive Officer & Director

Ms. Karen  Frechou-Armijo

Senior Vice President & Head of Human Resources

Mr. Kevin  Norrett M.B.A., M.S.

Chief Operating Officer

Carrie  McKim

Director of Investor Relations

Ms. Margaret Nell Fitzgerald J.D.

Chief Legal & Compliance Officer, General Counsel and Secretary

Mr. Sriram  Ryali M.B.A.

Chief Financial Officer

Βιοτεχνολογία

Codexis, Inc.

Codexis, Inc. Δομή της διοίκησης

Πληροφορίες για τη διοίκηση